Characteristic | N = 14 | % |
Age (year) |
| % |
Median | 54.5 |
|
Range | 40.5 - 84 |
|
Sex |
|
|
Male | 6 | 42.9 |
Female | 8 | 57.1 |
KPS (Karnofsky performance status score) |
|
|
100 | 1 | 7.1 |
90 | 4 | 28.6 |
80 | 4 | 28.6 |
70 | 3 | 21.4 |
50 | 2 | 14.3 |
Pancreatic tumor location |
|
|
Head | 5 | 35.7 |
Tail | 3 | 21.4 |
Multicentric (head and body—4, head, body and tail—1, body and tail—1) | 6 | 42.9 |
Level of CA 19-9 |
|
|
Normal | 2 | 14.3 |
Elevated | 12 | 85.7 |
Metastatic sites in addition to the pancreas |
|
|
Lymph nodes | 8 | 57.1 |
Liver | 9 | 64.3 |
Lungs | 4 | 28.6 |
Peritoneal | 3 | 21.4 |
Spleen | 1 | 7.1 |
Intestine | 1 | 7.1 |
Ovary | 1 | 7.1 |
Biliary stent | 6 | 42.9 |
Whipple procedure | 4 | 28.6 |
Chemotherapy |
|
|
1-line | 7 | 50 |
2-line | 5 | 35.7 |
3-line and more | 2 | 14.3 |
Radiation therapy | 2 | 14.3 |